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Most hosts harbor multiple pathogens at the same time in disease epidemiology. Multiple pathogens have the potential for
interaction resulting in negative impacts on host fitness or alterations in pathogen transmission dynamics. In this paper we develop
a mathematical model describing the dynamics of HIV-malaria coinfection. Additionally, we extended our model to examine the
role treatment (of malaria and HIV) plays in altering populations’ dynamics. Our model consists of 13 interlinked equations which
allow us to explore multiple aspects of HIV-malaria transmission and treatment. We perform qualitative analysis of the model
that includes positivity and boundedness of solutions. Furthermore, we evaluate the reproductive numbers corresponding to the
submodels and investigate the long term behavior of the submodels. We also consider the qualitative dynamics of the full model.
Sensitivity analysis is done to determine the impact of some chosen parameters on the dynamics of malaria. Finally, numerical
simulations illustrate the potential impact of the treatment scenarios and confirm our analytical results.

1. Introduction
The existence of parasites and pathogens has been documented in every free-living species [1–3]. Furthermore,
most hosts are infected with multiple species of pathogenic
organisms, leading to individual hosts which are coinfected
[4, 5]. Coinfection occurs when two or more pathogen species
exist within an individual at the same time [4]. Thus, the
potential for interaction among cooccurring pathogens may
result in major consequences for both the host and pathogen
populations via negative impacts on host fitness or by altering
pathogen transmission [5, 6].
Studies of coinfections with pathogens that impact
humans have provided the most comprehensive exploration
of the change of effects of coinfecting pathogens. Human
Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) represents one pathogen which has
been documented to be particularly sensitive to coinfections.

Specifically, increases in viral load as a result of recurrent or
persistent coinfections, such as occuring when individuals
are infected with both HIV/AIDS and malaria, tuberculosis,
herpes simplex virus type 2, or helminths, may facilitate
the increase in HIV transmission at both individual and
population levels [7, 8].
The bidirectional and synergistical interactions of HIV
and Malaria is particularly concerning because because of
the geographic overlap between these two diseases in the
Sub-Saharan region of Africa. In 2013, approximately 1.5
million (1.3 million–1.6 million) adults and children became
infected with HIV [9]. Malaria epidemics are also widespread
in this region where it is estimated that there were 198
million cases of malaria in 2013 and an estimated 584,000
deaths [10]. Furthermore, in the year 2010, an estimated 216
million clinical episodes of malaria and 650,000 deaths were
registered in the world. Africa has the biggest disease burden,
where an estimated 91% of deaths occur in this region [11].
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Since both diseases are endemic to this region, and the time
scale of infection for both diseases can be several years, the
issue of coinfection plays a prominent role in understanding
disease dynamics for this region [12]. Recent theoretical
analyses examining the relationship between malaria and
HIV in Sub-Saharan Africa indicate that malaria disproportionately contributes to the increase in incidence of HIV in
the region [13]. In fact, without the amplification effect caused
by malaria, HIV decreases to extinction [13]. Furthermore,
empirical evidence demonstrates that individuals who live
in areas with high rates of the malaria parasite Plasmodium
falciparum have approximately twice the risk of being HIV
positive compared with individuals who live in areas with low
P. falciparum parasite rates [14]. Despite the importance of
understanding coinfection dynamics of these two diseases,
theoretical models exploring these relationships indicate a
large amount of change of variation surrounding the possible
outcome of HIV/AIDS-malaria coinfection dynamics for
disease incidence.
Recent theoretical work examining HIV-malaria coinfections has neglected a key element of the epidemiology of
these diseases, primarily the inclusion of treatment for one
or both diseases [7]. The main objective of this study is thus
to investigate the role of HIV treatment on the dynamics
of malaria. In this study we formulate a theoretical model
to explore population dynamics of HIV/AIDS-malaria coinfections. We decompose the model into submodels to gain
insights into the transmission dynamics of each infection.
Additionally we extended our model to examine the role
treatment (for both malaria and HIV/AIDS) plays in altering
populations dynamics. Our model consists of 13 interlinked
equations which allow us to explore multiple aspects of
transmission and treatment. We begin by first describing
the full model; then we evaluate the individual models for
positivity and boundedness of solutions, calculate 𝑅0 , the
basic reproduction number, and determine the stability of
both the disease-free and endemic equilibriums. Finally, we
use simulations to explore population-level disease dynamics.

2. HIV-Malaria Coinfection Model
We considered a sexually active human population subdivided into the following subpopulations: being susceptible to
all pathogens (𝑆), being exposed to malaria only (𝐸𝑀), being
infected with malaria only (𝐼𝑀), being infected with HIV
only (𝐼𝐻), having developed AIDS (𝐴 𝐻), being asymptomatic
for AIDS but infected with malaria (𝐼𝐻𝑀), and being symptomatic to both AIDS and malaria (𝐴 𝐻𝑀). In addition, we
have different states to represent the different stages of HIV
treatment: 𝑇𝐻 and 𝑇𝐴 represent proportion of individuals
receiving HIV treatment from 𝐼𝐻 and 𝐴 𝐻, respectively, and
𝑇𝐻𝑀 and 𝑇𝐴𝑀 are the coinfection states of the previous states
mentioned.
We assume that individuals in state 𝐴 𝐻𝑀 will first receive
treatment for malaria before starting HIV treatment to minimize drug complication issues. We also assume the average
recovery rate from malaria is less than a week, which is fast
compared to the slow HIV dynamics, but consistent with
observed recovery values for malaria. Newly sexually active
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individuals are recruited to the human population at a rate
Λ 𝐻. Individuals in state 𝐸𝑀 either progress to symptomatic
stage at a rate 𝑝 or recover naturally at a rate 𝜙. The rate
at which malaria infected individuals recover from malaria
is 𝛾. Here we introduce scaling parameters 𝜖1 and 𝜖2 for
the recovery rates from states 𝐼𝐻𝑀 and 𝐴 𝐻𝑀, respectively.
These parameters are assumed to be less than 1, with 𝜖1 >
𝜖2 to account for the fact that coinfected individuals have
compromised immune systems, whereas 𝜂1 , 𝜂2 , 𝜂3 , and 𝜂4
(each assumed to be greater than 1) scale the force of infection
term for malaria (𝜆 𝑀) to account for individuals’ history
of HIV/AIDS infection. The rates at which HIV infected
individuals and those coinfected with malaria progress to
AIDS stages (𝐴 𝐻 and 𝐴 𝐻𝑀, resp.) are represented by 𝛼1 and
𝛼2 .
Since our main interest is to study the impact of HIV
treatment on the reduction of malaria cases, we consider a
hypothetical situation where individuals are adherent to HIV
treatment. For this study, we assume that individuals who
start treatment stay in the treatment program for the rest of
their lives. Individuals die of malaria at a rate 𝛿𝑀, where 𝜏 > 1
indicates an increase in the risk of death due to coinfection
with HIV for individuals in states 𝐼𝐻𝑀, 𝐴 𝐻𝑀, 𝑇𝐻𝑀, and 𝑇𝐴𝑀.
Similarly, we have a scaling parameter, 𝜑 < 1, for HIV/AIDS
induced death due to treatment for 𝑇𝐻 and 𝑇𝐴, where 𝛿𝐻
is an HIV/AIDS induced death rate for individuals in 𝐼𝐻.
Individuals on HIV treatment coinfected with malaria can
recover from malaria at a rate 𝑞.
The mosquito population 𝑁𝑉 is subdivided into susceptible mosquitoes (𝑆𝑉 ), mosquitoes exposed to the parasite
(𝐸𝑉), and infectious mosquitoes (𝐼𝑉). Susceptible mosquitoes
are generated at a constant rate Λ 𝑉 and acquire malaria
infection (following effective contacts with humans infected
with malaria) at force of infection rate 𝜆 𝑉. Mosquitoes are
assumed to suffer natural death at a rate 𝜇𝑉 , regardless of
their infection status. Newly infected mosquitoes are moved
into the exposed class (𝐸𝑉 ) and progress to the class of
symptomatic mosquitoes (𝐼𝑉) following the development of
symptoms at a rate 𝜃𝑉 .
Here we construct a system of equations to model the disease dynamics of HIV/AIDS and malaria. The assumptions
given above and the schematic diagrams (Figures 1 and 2)
result in the following system:
𝑑𝑆
= Λ 𝐻 + 𝜙𝐸𝑀 + 𝛾𝐼𝑀 − (𝜆 𝑀 + 𝜆 𝐻 + 𝜇) 𝑆,
𝑑𝑡
𝑑𝐸𝑀
= 𝜆 𝑀𝑆 − (𝜙 + 𝑝 + 𝜇) 𝐸𝑀,
𝑑𝑡
𝑑𝐼𝑀
= 𝑝𝐸𝑀 − (𝛾 + 𝑤𝜆 𝐻 + 𝜇 + 𝛿𝑀) 𝐼𝑀,
𝑑𝑡
𝑑𝐼𝐻
= 𝜆 𝐻𝑆 + 𝜖1 𝛾𝐼𝐻𝑀
𝑑𝑡
− (𝜂1 𝜆 𝑀 + 𝜌1 + 𝛼1 + 𝜇 + 𝛿𝐻) 𝐼𝐻,
𝑑𝑇𝐻
= 𝜌1 𝐼𝐻 + 𝑞𝑇𝐻𝑀 − (𝛼3 + 𝜂3 𝜆 𝑀 + 𝜇 + 𝜑𝛿𝐻) 𝑇𝐻,
𝑑𝑡
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Figure 1: HIV-malaria coinfection model (the human population).
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Figure 2: Vector population.

𝑑𝑇𝐴𝑀
= 𝜂4 𝜆 𝑀𝑇𝐴 + 𝛼4 𝑇𝐻𝑀 − (𝜎𝑞 + 𝜇 + 𝜏𝛿𝐴 ) 𝑇𝐴𝑀,
𝑑𝑡
𝑑𝑆𝑉
= Λ 𝑉 − (𝜆 𝑉 + 𝜇𝑉) 𝑆𝑉 ,
𝑑𝑡
𝑑𝐸𝑉
= 𝜆 𝑉𝑆𝑉 − (𝜃𝑉 + 𝜇𝑉 ) 𝐸𝑉,
𝑑𝑡

𝑑𝐴 𝐻
= 𝛼1 𝐼𝐻 + 𝜖2 𝛾𝐴 𝐻𝑀
𝑑𝑡

𝑑𝐼𝑉
= 𝜃𝑉𝐸𝑉 − 𝜇𝑉 𝐼𝑉.
𝑑𝑡
(1)

− (𝜂2 𝜆 𝑀 + 𝜌2 + 𝜇 + 𝛿𝐴 ) 𝐴 𝐻,
𝑑𝑇𝐴
= 𝜌2 𝐴 𝐻 + 𝛼3 𝑇𝐻 + 𝜎𝑞𝑇𝐴𝑀
𝑑𝑡

The total human and vector populations are, respectively,
given by

− (𝜂4 𝜆 𝑀 + 𝜇 + 𝜑𝛿𝐴 ) 𝑇𝐴,
𝑑𝐼𝐻𝑀
= 𝜂1 𝜆 𝑀𝐼𝐻 + 𝑤𝜆 𝐻𝐼𝑀
𝑑𝑡
− (𝜖1 𝛾 + 𝛼2 + 𝜇 + 𝜏𝛿𝑀) 𝐼𝐻𝑀,
𝑑𝐴 𝐻𝑀
= 𝛼2 𝐼𝐻𝑀 + 𝜂2 𝜆 𝑀𝐴 𝐻 − (𝜖2 𝛾 + 𝜇 + 𝜏𝛿𝐴) 𝐴 𝐻𝑀,
𝑑𝑡

𝑁𝐻 = 𝑆 + 𝐸𝑀 + 𝐼𝑀 + 𝐼𝐻 + 𝐼𝐻𝑀 + 𝐴 𝐻 + 𝐴 𝐻𝑀 + 𝑇𝐻
+ 𝑇𝐴 + 𝑇𝐻𝑀 + 𝑇𝐴𝑀,
𝑁𝑉 = 𝑆𝑉 + 𝐸𝑉 + 𝐼𝑉.

(2)
(3)
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Susceptible individuals get infected with HIV at a rate 𝜆 𝐻 and
with malaria at a rate 𝜆 𝑀, where
𝜆 𝐻 = 𝛽𝐻
𝜆𝑀

𝐼𝐻 + 𝜃1 𝐼𝐻𝑀 + 𝜃2 𝐴 𝐻 + 𝜃3 𝐴 𝐻𝑀 + 𝜃4 𝑇𝐻 + 𝜃5 𝑇𝐴 + 𝜃6 𝑇𝐻𝑀 + 𝜃7 𝑇𝐴𝑀
,
𝑁𝐻

Mosquitoes acquire malaria parasite from malaria infected
individuals at a rate 𝜆 𝑉 following effective transmission
probability 𝛽𝑉 and mosquito biting rate 𝑏𝑀 given by the
expression
𝜆 𝑉 = 𝛽𝑉𝑏𝑀

𝐼𝑀 + 𝑞1 𝐼𝐻𝑀 + 𝑞2 𝐴 𝐻𝑀 + 𝑞3 𝑇𝐻𝑀 + 𝑞4 𝑇𝐴𝑀
, (5)
𝑁𝐻

where 𝜃’s and 𝑞’s are factors indicating the differential
contribution for the HIV and malaria infection, respectively.
𝛽𝐻 is the effective contact rate for HIV infection, 𝛽𝑉 is the
transmission probability for mosquito infection, and 𝑏𝑀 is
the biting rate of mosquitoes. Summary of parameters in
the HIV-malaria coinfection model is shown in Notations
section.
Before analyzing the dynamics of the full model, we
first consider the submodels (HIV-only and malaria-only)
separately.

3. HIV-Only Model
The HIV-only model is obtained by setting states of malaria
infection and coinfection equal to zero in (1) and is described
by the following equations:

Model Properties. Following [15], we have the following
theorem on the positivity and invariance of system (6).
Theorem 1. (1) The region RH given by
RH = {𝑆 (𝑡) , 𝐼𝐻 (𝑡) , 𝐴 𝐻 (𝑡) , 𝑇𝐻 (𝑡) , 𝑇𝐴 (𝑡) ∈ R5+ : 𝑁𝐻

𝑑𝑆
= Λ 𝐻 − (𝜆 𝐻 + 𝜇) 𝑆,
𝑑𝑡

is positively invariant and attracting with respect to model
system (6).
(2) The solutions (𝑆(𝑡), 𝐴 𝐻(𝑡), 𝑇𝐻(𝑡), 𝑇𝐴(𝑡)) of model (6)
are positive for all 𝑡 ≥ 0 for any given nonnegative initial
conditions.
3.1. The Basic Reproduction Number, 𝑅0𝐻. We use the nextgeneration matrix method to determine the basic reproduction number, 𝑅0𝐻, of the submodel.
The basic reproduction number is given by
𝑅0𝐻 = 𝜁 (𝐹𝑉−1 )

(6)

𝑑𝑇𝐻
= 𝜌1 𝐼𝐻 − (𝛼3 + 𝜇 + 𝜑𝛿𝐻) 𝑇𝐻,
𝑑𝑡

Λ𝐻
, 0, 0, 0, 0) .
𝜇

(10)

Local stability of 𝜀𝐻0 is guaranteed by using Theorem 2
in [16]. However, global stability can be established using the
method first outlined in [17]. We thus have the following
theorem.

where 𝜆 𝐻 is the force of infection term given by

with 𝑁𝐻 = 𝑆 + 𝐼𝐻 + 𝐴 𝐻 + 𝑇𝐻 + 𝑇𝐴 .

(9)

3.2. Stability of the Disease-Free Equilibrium. The disease-free
equilibrium point, 𝜀𝐻0 of the HIV-only model, is obtained by
setting all the infectious classes to zero so that
𝜀𝐻0 = (𝑆, 𝐼𝐻, 𝐴 𝐻, 𝑇𝐻, 𝑇𝐴) = (

𝑑𝑇𝐴
= 𝛼3 𝑇𝐻 + 𝜌2 𝐴 𝐻 − (𝜇 + 𝜑𝛿𝐴 ) 𝑇𝐴,
𝑑𝑡

𝐼𝐻 + 𝜃2 𝐴 𝐻 + 𝜃4 𝑇𝐻 + 𝜃5 𝑇𝐴
,
𝑁𝐻

𝛽𝐻
𝜃𝜌
𝜃𝛼𝜌
𝜃𝛼𝜌
𝜃𝛼
(1 + 2 1 + 4 1 + 5 3 1 + 5 1 2 ) ,
𝐾
𝐿
𝑀
𝑀𝑁
𝐿𝑁

where 𝐾 = 𝛿𝐻 + 𝜇 + 𝛼1 + 𝜌1 , 𝐿 = 𝜇 + 𝛿𝐴 + 𝜌2 , 𝑀 = 𝜇 + 𝜑𝛿𝐻 + 𝛼3 ,
𝑁 = 𝜇 + 𝜑𝛿𝐴 .

𝑑𝐼𝐻
= 𝜆 𝐻𝑆 − (𝜌1 + 𝛼1 + 𝜇 + 𝛿𝐻) 𝐼𝐻,
𝑑𝑡
𝑑𝐴 𝐻
= 𝛼1 𝐼𝐻 − (𝜌2 + 𝜇 + 𝛿𝐴 ) 𝐴 𝐻,
𝑑𝑡

(8)

Λ
≤ 𝐻}
𝜇

=

𝜆 𝐻 = 𝛽𝐻

(4)

𝐼
= 𝛽𝑀𝑏𝑀 𝑉 .
𝑁𝐻

(7)

Theorem 2. The fixed point 𝑈0 = (𝑋∗ ; 0) = (Λ 𝐻/𝜇, 0, 0, 0, 0)
is a globally asymptotic stable equilibrium of system (6) if
𝑅0𝐻 < 1.
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3.3. The Endemic Equilibrium. The endemic equilibrium
point of the system is given by
∗
∗
∗
= (𝑆∗ , 𝐼𝐻
, 𝐴∗𝐻, 𝑇𝐻
, 𝑇𝐴∗ ) ,
𝜀𝐻

(11)

We choose 𝛽𝐻 as a bifurcation parameter. It can be shown
∗
has a right eigenvector
that the Jacobian matrix at 𝛽𝐻 = 𝛽𝐻
associated with the zero eigenvalue. Evaluation of the right
and left eigenvectors aids the determination of the coefficients
a and b. We thus have

where

𝑛

a = ∑ V𝑘 𝑤𝑖 𝑤𝑗
𝑆∗ =
∗
𝐼𝐻

𝐴∗𝐻

𝑘,𝑖,𝑗=1

Λ 𝐻 𝐾Λ 𝐻 (𝑅0𝐻 − 1)
,
+
𝜇
𝜇 (𝛽𝐻Γ − 𝜇𝜓)

∗
𝑇𝐻
=

𝜌1 Λ 𝐻 (𝑅0𝐻 − 1)
,
𝑀 (𝛽𝐻Γ − 𝜇𝜓)

𝑇𝐴∗ =

Λ 𝐻 (𝐿𝛼3 𝜌1 + 𝑀𝛼1 𝜌2 ) (𝑅0𝐻 − 1)
,
𝐿𝑀𝑁 (𝛽𝐻Γ − 𝜇𝜓)

(16)

which gives

Λ (𝑅 − 1)
= 𝐻 0𝐻
,
𝛽𝐻Γ − 𝜇𝜓
𝛼 Λ (𝑅 − 1)
= 1 𝐻 0𝐻
,
𝐿 (𝛽𝐻Γ − 𝜇𝜓)

𝜕2 𝑓𝑘
(0, 0) ,
𝜕𝑥𝑖 𝜕𝑥𝑗

a=−

(12)

1
2
𝛽 𝜇3 (𝜇 + 𝜑𝛿𝐴 ) (𝜇 + 𝛼3 + 𝜑𝛿𝐻) (𝜇 + 𝛿𝐴
Λ𝐻 𝐻
2

+ 𝜌2 ) (2 (𝜇 + 𝜑𝛿𝐴 ) (𝜇 + 𝛼3 + 𝜑𝛿𝐻) + (𝜇 + 𝛼3
+ 𝜑𝛿𝐻) ((𝜇 + 𝜑𝛿𝐴 ) (1 + 𝜃4 ) + 𝛼3 (1 + 𝜃5 )) 𝜌1 + ((𝛼3
2

+ 2 (𝜇 + 𝜑𝛿𝐴 )) 𝜃4 + 𝛼3 𝜃5 ) 𝜌2 ) (𝜇 + 𝛿𝐴 + 𝜌2 )
2

+ 𝛼12 (𝜇 + 𝛼3 + 𝜑𝛿𝐻) (2 (𝜇 + 𝜑𝛿𝐴 ) 𝜃2 + (𝜃2 + 𝜃5 )

(17)

⋅𝜌2 ) + 𝛼1 (𝜇 + 𝛼3 + 𝜑𝛿𝐻) (𝜇 + 𝛿𝐴 + 𝜌2 ) (((𝜇

with
𝜃𝜌
𝜃𝛼𝜌
𝜃𝛼𝜌
𝜃𝛼
Γ = 1 + 2 1 + 4 1 + 5 3 1 + 5 1 2,
𝐿
𝑀
𝑀𝑁
𝐿𝑁
𝜓=

𝜌
𝛼𝜌
𝛼𝜌
𝛼
𝐾
− (1 + 1 + 1 + 3 1 + 1 2 ) .
𝜇
𝐿 𝑀 𝑀𝑁 𝐿𝑁

+ 𝜑𝛿𝐴 ) ((𝜇 + 𝜑𝛿𝐻) (1 + 𝜃2 ) + (𝜃2 + 𝜃4 ) 𝜌1 )
+ ((𝜇 + 𝜑𝛿𝐻) (1 + 𝜃5 ) + (𝜃4 + 𝜃5 ) 𝜌1 ) 𝜌2 + 𝛼3 (𝜇

(13)

+ 𝜃5 (𝜌1 + 𝜌2 )))) .

Remark 3. Given that 𝑅0𝐻 = 𝛽𝐻Γ/𝐾 is the basic reproduction
∗
reduces to 𝜀𝐻0 .
number, when 𝑅0𝐻 = 1, 𝜀𝐻
We use the Center Manifold Theory described in [18] to
study the local stability of the endemic equilibrium point
(close to 𝑅0𝐻 = 1). We apply Theorem 4.1 duplicated as
Theorem A.1 in the Appendix for ease of reference. Model
system (6) can be rewritten as follows using change of
variables:
𝑑𝑋
= 𝐹 = (𝑓1 , 𝑓2 , 𝑓3 , 𝑓4 , 𝑓5 ) ,
𝑑𝑡

+ 𝜑𝛿𝐴 (1 + 𝜃2 ) + 𝜃2 (𝜇 + 𝜌1 ) + 𝜌2

(14)

Similarly,
𝑛

b = ∑ V𝑘 𝑤𝑖
𝑘,𝑖=1

𝜕2 𝑓𝑘
(0, 0)
𝜕𝑥𝑖 𝜕𝛽𝐻

results in
𝑏 = 𝜇 (𝜇 + 𝜑𝛿𝐴 ) (𝜇 + 𝛼3 + 𝜑𝛿𝐻) (𝜇 + 𝛿𝐴 + 𝜌2 )
⋅ (𝛼1 (𝜇 + 𝜑𝛿𝐴 ) (𝜇 + 𝛼3 + 𝜑𝛿𝐻) 𝜃2

such that

+ (𝜇 + 𝜑𝛿𝐴 ) (𝜇 + 𝛼3 + 𝜑𝛿𝐻) (𝜇 + 𝛿𝐴 + 𝜌2 )

𝑥1 (𝑡) = 𝑓1 = Λ 𝐻 − (𝜆 𝐻 + 𝜇) 𝑥1 ,

+ (𝜇 + 𝜑𝛿𝐴 ) 𝜃4 𝜌1 (𝜇 + 𝛿𝐴 + 𝜌2 )

𝑥2 (𝑡) = 𝑓2 = 𝜆 𝐻𝑥1 − (𝜌1 + 𝛼1 + 𝜇 + 𝛿𝐻) 𝑥2 ,

+ 𝜃5 (𝛼1 (𝜇 + 𝛼3 + 𝜑𝛿𝐻) 𝜌2 + 𝛼3 𝜌1 (𝜇 + 𝛿𝐴 + 𝜌2 ))) .

𝑥3 (𝑡) = 𝑓3 = 𝛼1 𝑥2 − (𝜌2 + 𝜇 + 𝛿𝐴 ) 𝑥3 ,
𝑥4 (𝑡) = 𝑓4 = 𝜌1 𝑥2 − (𝛼3 + 𝜇 + 𝜑𝛿𝐻) 𝑥4 ,
𝑥5

(𝑡) = 𝑓5 = 𝛼3 𝑥4 + 𝜌2 𝑥3 − (𝜇 + 𝜑𝛿𝐴 ) 𝑥5 .

(18)

(15)

(19)

Thus, 𝑎 < 0 and 𝑏 > 0. We thus have the following theorem.
Theorem 4. The endemic equilibrium is locally asymptotically
stable for 𝑅0𝐻 near 1.
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4. Malaria-Only Model
In a similar way, if we set states of HIV and coinfection equal
to zero in (1), we obtain malaria-only model described by the
following system of equations:
𝑑𝑆
= Λ 𝐻 + 𝜙𝐸𝑀 + 𝛾𝐼𝑀 − (𝜆 𝑀 + 𝜇) 𝑆,
𝑑𝑡

(2) All solutions (𝑆(𝑡), 𝐸𝑀(𝑡), 𝐼𝑀(𝑡), 𝑆𝑉 (𝑡), 𝐸𝑉(𝑡), 𝐼𝑉(𝑡)) of
model (20) are bounded.
4.2. The Basic Reproduction Number, 𝑅0𝑀. The associated
basic reproduction number 𝑅0𝑀 of the model is given by

𝑑𝐸𝑀
= 𝜆 𝑀𝑆 − (𝜙 + 𝑝 + 𝜇) 𝐸𝑀,
𝑑𝑡
𝑑𝐼𝑀
= 𝑝𝐸𝑀 − (𝛾 + 𝜇 + 𝛿𝑀) 𝐼𝑀,
𝑑𝑡
𝑑𝑆𝑉
= Λ 𝑉 − (𝜆 𝑉 + 𝜇𝑉 ) 𝑆𝑉,
𝑑𝑡

ℎ
V
𝑅0𝑀 = 𝜁 (𝐹𝑉−1 ) = √𝑅0𝑀
𝑅0𝑀
,

where
(20)
ℎ
=
𝑅0𝑀

𝑑𝐸𝑉
= 𝜆 𝑉𝑆𝑉 − (𝜃𝑉 + 𝜇𝑉) 𝐸𝑉,
𝑑𝑡

V
𝑅0𝑀

𝑑𝐼𝑉
= 𝜃𝑉 𝐸𝑉 − 𝜇𝑉 𝐼𝑉.
𝑑𝑡
The force of infection terms for malaria infection from
mosquito to human and vice versa is given by 𝜆 𝑀 and 𝜆 𝑉,
respectively, where
𝜆 𝑀 = 𝛽𝑀𝑏𝑀

𝐼𝑉
,
𝑁𝐻

𝐼
𝜆 𝑉 = 𝛽𝑉𝑏𝑀 𝑀 .
𝑁𝐻

(21)

4.1. Model Properties. The following results can easily be
established on the positivity and boundedness of the solutions of system (20) in the feasible region
Ω ⊆ Ω𝐻 × Ω𝑉,

(22)

where
Ω𝐻 = {(𝑆, 𝐸𝑀, 𝐼𝑀) | 𝑁𝐻 ≤

Λ𝐻
,𝑆
𝜇

≤

Λ2𝐻𝜇𝑉 (𝜙 + 𝛾 + 𝜇)
,𝐸
𝜇 (𝛽𝑀𝑏𝑀Λ 𝑉𝜇 + (𝜙 + 𝛾 + 𝜇) Λ 𝐻𝜇𝑉) 𝑀

≤

𝛽𝑀𝑏𝑀Λ 𝑉 (𝜙 + 𝑝 + 𝜇)
,
(𝜙 + 𝑝 + 𝜇) (𝛽𝑀𝑏𝑀Λ 𝑉𝜇 + (𝜙 + 𝛾 + 𝜇) Λ 𝐻𝜇𝑉)

𝐸𝑉 ≤

𝑝𝛽𝑀𝜇
,
Λ 𝐻 (𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿𝑀)

𝑏2 𝛽 𝜃 Λ
= 2𝑀 𝑉 𝑉 𝑉 .
𝜇𝑉 (𝜃𝑉 + 𝜇𝑉)

(25)

ℎ
Here, 𝑅0𝑀
represents the contribution from the human
V
represents the contribution from the
population, while 𝑅0𝑀
vector population.

4.3. Stability of the Disease-Free Equilibrium. We begin by
determining the disease-free equilibrium point 𝜀𝑀0 of the
malaria-only model, by setting all the equations in (20) equal
to zero so that
𝜀𝑀0 = (𝑆, 𝐸𝑀, 𝐼𝑀, 𝑆𝑉, 𝐸𝑉, 𝐼𝑉)
=(

Λ
Λ𝐻
, 0, 0, 𝑉 , 0, 0) .
𝜇
𝜇𝑉

(26)

Following Theorem 2 stated in [16], we present local
stability property for the disease-free equilibrium in the
following theorem.
Theorem 6. The disease-free equilibrium of system (20) is
locally asymptotically stable whenever 𝑅0𝑀 < 1 and unstable
otherwise.
(23)

𝐼𝑀 ≥ 0} ,
Ω𝑉 = {(𝑆𝑉, 𝐸𝑉, 𝐼𝑉) | 𝑁𝑉 ≤

(24)

Λ𝑉
Λ𝑉
, 𝑆𝑉 ≤
,
𝜇𝑉
𝛽𝑉𝑏𝑀 + 𝜇𝑉

𝛽𝑉𝑏𝑀Λ 𝑉
, 𝐼 ≥ 0} .
(𝛽𝑉𝑏𝑀 + 𝜇𝑉 ) (𝜃𝑉 + 𝜇𝑉) 𝑉

Theorem 5. (1) The solutions (𝑆(𝑡), 𝐸𝑀(𝑡), 𝐼𝑀(𝑡), 𝑆𝑉(𝑡), 𝐸𝑉(𝑡),
𝐼𝑉(𝑡)) of model (20) are positive for all 𝑡 ≥ 0 for nonnegative
initial conditions.

The global stability of (20) follows [17]. We thus have the
following theorem.
Theorem 7. The fixed point 𝑈0 = (𝑋∗ ; 0) = (Λ 𝐻/𝜇, Λ 𝑉/𝜇𝑉 ,
0, 0, 0, 0) is a globally asymptotic stable (g.a.s) equilibrium of
system (20) if 𝑅0𝑀 < 1.
4.4. The Endemic Equilibrium. The endemic equilibrium
point of (20) is given by
∗
∗
∗
∗ ∗
, 𝐼𝑀
, 𝑆𝑉
, 𝐸𝑉
, 𝐼𝑉) ,
𝜀𝑀1 = (𝑆∗ , 𝐸𝑀

(27)
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Table 1: Parameter estimation.

where
𝑆∗
(𝛾 + 𝜇 + 𝛿𝑀) (𝜙 + 𝑝 + 𝜇) Λ 𝐻
=
,
𝜇 (𝜙 + 𝑝 + 𝜇) 𝛾 + 𝜇 + 𝛿𝑀 + 𝜆∗𝑀 (𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿𝑀)
∗
𝐸𝑀

𝜆∗𝑀Λ 𝐻 (𝛾 + 𝜇 + 𝛿𝑀)
,
𝜇 (𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿𝑀) + 𝜆∗𝑀 (𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿𝑀)

=
∗
𝐼𝑀

=

𝑝𝜆∗𝑀Λ 𝐻
,
𝜇 (𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿𝑀) + 𝜆∗𝑀 (𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿𝑀)
Λ𝑉
,
𝜆∗𝑉 + 𝜇𝑉

∗
𝑆𝑉
=
∗
=
𝐸𝑉

𝐼𝑉∗ =

(28)

(𝜆∗𝑉

𝜆∗𝑉Λ 𝑉
,
+ 𝜇𝑉) (𝜃𝑉 + 𝜇𝑉 )

𝜇𝑉 (𝜆∗𝑉

𝜆∗𝑉Λ 𝑉𝜃𝑉
.
+ 𝜇𝑉 ) (𝜃𝑉 + 𝜇𝑉)

Note that
𝜆∗𝑀 = 𝛽𝑀𝑏𝑀
𝜆∗𝑉

𝐼𝑉∗
,
∗
𝑁𝐻

𝐼∗
= 𝛽𝑉𝑏𝑀 𝑀∗ ,
𝑁𝐻

(29)

∗
∗
∗
where 𝑁𝐻
= 𝑆∗ + 𝐸𝑀
+ 𝐼𝑀
.
Using the Center Manifold Theory [18] to study the local
ℎ
),
stability of the endemic equilibrium point (very close to 𝑅0𝑀
we have the corresponding coefficients a and b as

a = 𝑎+ − 𝑎− ,

(30)

where

2

2 2 2 2
⋅ 𝜃𝑉 Λ2𝑉𝜇𝑉 (𝜃𝑉 + 𝜇𝑉) (𝑏𝑀
𝑝 𝛽𝑉𝜇

(31)

3
2
𝑝𝛽𝑀
𝛽𝑉𝜇4 (𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿𝑀)
𝑎− = 𝑏𝑀

𝛿𝑀) Λ 𝐻𝜇𝑉2 ) .

Also
b = 𝑏𝑀𝑝𝛽𝑀𝛽𝑉 𝜇2 (𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿𝑀)

⋅ (𝛿𝑀Λ 𝑉𝜇𝑉 + Λ 𝐻𝜇𝑉2 − 2𝑏𝑀𝛽𝑉𝜇Λ 𝑉) .

Remark 9. The existence of a backward bifurcation impacts
the design of malaria control measures, since an epidemic
ℎ<1
may persist even 𝑅0𝑀
.

5. Numerical Simulations

2

⋅ 𝜃𝑉 Λ 𝑉𝜇𝑉2 (𝜃𝑉 + 𝜇𝑉) (2𝑏𝑀𝑝𝛽𝑉 𝛿𝑀Λ 𝑉 + (𝑝 + 𝛾

⋅ 𝜃𝑉Λ 𝑉 (𝜃𝑉 + 𝜇𝑉)

The signs of the coefficients above are not known; hence
we put conditions for the existence of backward bifurcation.

(ii) 𝛿𝑀Λ 𝑉𝜇𝑉 + Λ 𝐻𝜇𝑉2 > 2𝑏𝑀𝛽𝑉𝜇Λ 𝑉.

2

+𝜇+

Reference
[19]
[20, 21]
Estimate
Estimate
[21, 22]
Estimate
[21, 22]
[21, 22]
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate

(i) 𝑎+ > 𝑎− ,

+ (𝜇2 (𝑝2 + 𝑝 (𝛾 + 𝜇) + (𝛾 + 𝜇) )

2
+ (𝑝2 + 𝑝𝜇 + 𝜇2 ) 𝛿𝑀
) 𝜇𝑉2 ) ,

Current value
(1.932/365) 𝑁ℎ0
6𝑁V0
2.5/365
0.2/365
0.08333/365
0.9
0.02/365, 0.1429/365
3.54 × 10−4
0.05/365
0.2/365
0.15
0.5
0.567/365
0.05
0.5/365
0.7
0.0005 each
0.015/365 each
0.5/365, 0.05/365
1.2 each
0.2 each
1 each
0.5, 1.01
0.1

Lemma 8. The system exhibits backward bifurcation if the
following conditions satisfy

3 2
𝑎+ = 2𝑏𝑀
𝛽𝑀𝛽𝑉𝜇3 (𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿𝑀)

+ 𝜇 (𝑝2 + 2𝜇 (𝛾 + 𝜇) + 𝑝 (𝛾 + 2𝜇)) 𝛿𝑀

Parameters
Λ𝐻
Λ𝑉
𝛾
𝜙
𝑝
𝑤
𝜇, 𝜇𝑉
𝛿𝑀
𝛿𝐻
𝛿𝐴
𝑏𝑀
𝛽𝑀
𝛽ℎ
𝛽𝑉
𝑞
𝜎
𝛼1,2,3,4
𝜌1,2
𝜖1,2
𝜂1,2,3,4
𝜃1,2,3,4,5,6,7
𝑞1,2,3,4
𝜑, 𝜏
𝜃𝑉

(32)

The full model is complicated to carry out mathematical
analyses. The matrix for the full model will be 14 by 14 square
matrix. Hence we only focused on the numerical simulations
of the full model (1). The set of parameter values are given in
Table 1.
Our model demonstrates interesting mathematical results
which extend to important implications for disease management. Specifically, we show cyclical dynamics which indicate
the coexistence of malaria and HIV is dependent upon the
presence of both pathogens and is sensitive to a number
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Figure 3: Sensitivity indices for the reproduction numbers: (a) HIV-only model and (b) malaria-only model. 𝑅0𝐻 is positively affected by
changes in 𝛽𝐻 and 𝜃𝑉 . Increasing the values of 𝑏𝑀 , 𝛽𝑀 , 𝛽𝑉 , and 𝜃𝑉 increases 𝑅0𝑀 , while changes to the parameters 𝛾 and 𝜙 have opposite effect
on the value of 𝑅0𝑀 .

of parameters which determine disease severity. We also
demonstrate the importance of treatment for maintaining
coexistence rather than disease induced extinction and further explore the role starting treatment plays in changing
disease dynamic.
5.1. Coexistence. For our model, coexistence can only occur
when the number of new malaria cases generated from
a single malaria case is sufficiently low to sustain HIV
infected individuals. Specifically, our simulations indicate
that both HIV dynamics and malaria dynamics fluctuate but
HIV dynamics synchronize with malaria dynamics such that
population crashes as a result of malaria infections causing
the number of HIV infected individuals to decrease. This is
similar to previous work which also found the amplification
effect caused by coinfection between malaria and HIV was
responsible for maintaining HIV in Sub-Saharan Africa [14].
The importance of such fluctuations may further be explained
when considering the sensitivities of 𝑅0 for the individual
disease models with respect to their parameters. Interestingly,
𝑅0 ’s of our individual disease models are particularly sensitive
to parameters which relate to transmission probabilities.
While 𝑅0 associated with HIV is strongly and positively influenced by changes to the direct transmission parameter 𝛽𝐻
(the contact rate between a human with HIV and a susceptible
human), 𝑅0 associated with malaria is strongly and positively
influenced by changes to the indirect transmission parameter
𝑏𝑀 (the mosquito biting rate); however, 𝑅0 associated with
malaria is less sensitive to the direct transmission parameters
𝛽𝑀 and 𝛽𝑉 (the transmission probability of malaria) but
this relationship is still positive (Figure 3). Unsurprisingly,
changes in parameters associated with recovery from malaria

(𝛾 and 𝜙) are likely to decrease 𝑅0 associated with malaria
(Figure 3(b)). Thus alterations in the individual disease
transmission caused by coinfection with another pathogen
are likely to increase the severity of infection of one or both
diseases and alterations in the ability of an individual to
recover from malaria caused by coinfection with HIV will
also lead to increase in disease severity.
This sensitivity to 𝑅0 may be an indicator of the role
intrahost pathogen dynamics play in altering the success of
multiple pathogens when individuals are coinfected. While
we hypothesized that the severe impairment, HIV imposes
on the host immune system, would allow malaria infection
to progress more quickly [23], it appears that HIV infection
actually acts to increase the rate at which individuals move
from the malaria exposed class to the malaria infected class
for malaria only which lowers the overall 𝑅0 for the system.
This increase in disease progression may explain why malaria
treatment is more likely to fail for HIV-infected individuals
[24, 25] and help explain why patients infected with both
malaria and HIV are more likely to experience symptoms
associated with severe/complicated malaria [26], but further
work is needed to confirm this mechanism. Additionally,
we demonstrate similar dynamics with mosquitoes such that
coinfection hinders disease progression of malaria when
mosquitoes feed on hosts infected with both HIV and malaria
(Figure 4). This suggests that the HIV RNA virus is interacting with the malaria parasite Plasmodium to alter its success
in both the host and the vector, supporting previous research
which indicates intrahost dynamics play an important role in
explaining the effects of malaria-HIV coinfection [27].
Our model indicates an important relationship between
HIV/AIDS and malaria infection such that the number of
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Figure 4: Plots for the vector population: (a) susceptible (𝑆𝑉 ), (b) exposed (𝐸𝑉 ), and (c) infected (𝐼𝑉 ) vectors. Here the source of malaria
infection is assumed to be only from malaria infected patients.

HIV infected individuals peaks earlier when individuals are
singularly infected with HIV/AIDS (Figures 5(a) and 5(c))
compared to when they are coinfected with HIV or AIDS
(Figures 5(b) and 5(d)). In other words, in our model, the
presence of malaria delays the start of infections dynamics
of HIV but speeds up the progression of the disease. This
suggests that coinfection with malaria can be especially
detrimental to those individuals infected with HIV/AIDS,
possibly as a result of increases in viral load which result from
coinfection [28].
5.2. Treatment. Our model also has important implications
for treatment as it indicates a key interaction between the
rate of treatment for HIV/AIDS and malaria infection such
that the number of HIV infected individuals decreases in all
classes when individuals are on treatment (Figure 6) compared to when individuals are not on treatment (Figure 5).
Specifically, this translates to a decrease in the number of new
HIV infections (Figure 7(a)) and the number of new malaria
cases (Figure 7(b)) for individuals receiving treatment compared to individuals who do not receive treatment. This is
especially important for individuals coinfected with AIDS
and malaria as increasing the rate individuals start treatment
(𝜌) decreases the number of infected individuals (Figure 8).
Interestingly, treatment for individuals only infected with

AIDS leads to a stable equilibrium earlier than when individuals with AIDS do not receive treatment (Figures 5(c)
and 6(c)). Such results strongly suggest that increasing the
availability and effectiveness of treatment for HIV will help
dampen not only HIV/AIDS dynamics but also decrease the
severity of malaria infection.
Furthermore, similar dynamics occur with malaria.
While we did not specifically account for treatment of
malaria, we did allow for individuals with malaria to recover
naturally. Perhaps unsurprisingly, increasing this rate (𝛾)
decreases 𝑅0 specific to malaria (Figure 9).
When HIV is considered independently of malaria, we
see that treatment does not significantly alter the HIV prevalence in the population, but it does alter disease dynamics
such that increasing the rate at which individuals start
treatment (𝜌) can slightly delay increases in population
prevalence over time but does not alter the duration for
infection (Figure 10).
Similarly, when malaria infection is considered independently of HIV, we see that treatment does not significantly
alter the number of malaria cases in the population, but it
does alter disease dynamics such that increasing the rate
at which individuals start treatment (𝜌) can slightly delay
increases in population prevalence over time but does not
alter the duration for infection (Figure 11).
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Figure 5: Plots for individuals not on HIV treatment as we vary the progression rate from exposed to malaria infected. HIV, 𝐼𝐻 (a); coinfected
with HIV and malaria, 𝐼𝐻𝑀 (b); infected with AIDS, 𝐴 𝐻 (c); coinfected with AIDS and malaria, 𝐴 𝐻𝑀 (d). Only the number of coinfected
individuals varies as we vary 𝜌. In panel (d), increases in the thickness of the line indicate increases in parameter 𝜌 (progress rate from exposed
to malaria infected classes).

6. Conclusion
Our model emphasizes the importance of considering HIVmalaria coinfection when considering disease dynamics in
Sub-Saharan Africa. We further demonstrate amplification
in HIV/AIDS prevalence as a result of malaria coinfection;
however, we also demonstrate the importance of treatment
for mitigating this dynamic, especially for AIDS infected
patients. Therefore, we advocate for continued efforts to
increase access to treatment as a means of mitigating the
harmful effects of malaria-HIV coinfection.
Although our model represents a significant step forward in modeling the interaction of HIV/AIDS dynamics
with malaria dynamics by including treatment, it is limited
in a few ways. First, for individuals coinfected with both
pathogens, HIV infection always occurs prior to acquiring
malaria. This limits our ability to infer whether individuals
who have malaria and then acquire HIV demonstrate the
same dynamics; thus, future theoretical work is needed to
explore this phenomenon. Second, our model is limited by
parameterization. While we were able to acquire some of
our parameter values from the literature, we had to estimate
many of the other parameters. This may influence simulation

dynamics. Consequently, we encourage future collaborative
research with empiricists to develop experiments which
will explicitly measure some of the parameters which are
currently estimates in order to better inform future models.
Despite these shortcomings, the model presents some
interesting results on the benefits of HIV treatment to malaria
control. This is particularly important in Sub-Saharan Africa
where the coexistence of Malaria and HIV/AIDS is more
conspicuous.

Appendix
Center Manifold Theory
We apply Center Manifold Theory (CMT) as described in
[18] to establish the local stability of an endemic equilibrium
point and check for the existence of backward bifurcation. It
is applicable in deciding the local stability of a nonhyperbolic
equilibrium (linearisation matrix which has at least one
eigenvalue with a zero real part). The theory determines not
only the local stability of the nonhyperbolic equilibrium but
also the existence of a backward bifurcation. We duplicate
Theorem 4.1 in [18] for the convenience of the reader.
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Figure 6: Plots for individuals receiving HIV treatment as we vary the progression rate from exposed to malaria infected. HIV, 𝐼𝐻 (a);
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coinfected individuals varies as we vary 𝜌. In panel (d), increases in the thickness of the line indicate increases in parameter 𝜌 (progress rate
from exposed to malaria infected classes).

100

45

90

40

80

35

New malaria cases

New HIV infections

70
60
50
40
30

25
20
15
10

20

5

10
0

30

0

5

10 15 20 25 30 35 40 45 50
Time (years)
(a)

0

0

5

10 15 20 25 30 35 40 45 50
Time (years)
(b)

Figure 7: Number of new infections cases: (a) HIV infections and (b) malaria cases for individuals for two different scenarios. Solid line is a
plot where there is HIV treatment, whereas the broken line is for the scenario where individuals do not receive HIV treatment. The number of
new HIV infections and malaria cases is calculated by multiplying the respective force of infection with the number of susceptible individuals
to HIV and malaria, respectively.

BioMed Research International
70

45

60

40
HIV prevalence (%)

HIV/AIDS attributed deaths

12

50
40
30
20
10
0

35
30
25
20
15
10
5

0

5

10

15

20

25 30 35
Time (years)

40

45

0

50

0

5

10

15

20

25

30

35

40

45

50

Time (years)

Figure 8: The number of HIV/AIDS attributed deaths for individuals receiving treatment (thin line) and for individuals who do not
receive treatment (thick line).

Figure 10: HIV prevalence (number of infected individuals/total
population) as function of time. The thicker the curve, the larger the
rate at which individuals start treatment (𝜌).
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Consider a general system of differential equations with
parameter Φ (which will be considered as a bifurcation
parameter):
𝑑𝑥
= 𝑓 (𝑥, Φ) ,
𝑑𝑡

(A.1)
𝑛

2

𝑛

𝑓 : R × R → R , 𝑓 ∈ C (R × R) .

Without loss of generality, it is assumed that 0 is an equilibrium for system for all values of parameter Φ; that is,
𝑓 (0, Φ) ≡ 0,

∀Φ.

(A.2)

We state the theorem as follows.
Theorem A.1. Assume the following.
(1) 𝐴 = 𝐷𝑥 𝑓(0, 0) = ((𝜕𝑓𝑖 /𝜕𝑥𝑗 )(0, 0)) is the linearisation
matrix of system around equilibrium 0 with Φ evaluated at 0. Zero is a simple eigenvalue of A and all other
eigenvalues of 𝐴 have negative real parts.

25 30 35
Time (years)

40

45

50

Figure 11: The number of malaria cases per 100,000 people as
function of time. The thicker the curve, the larger the rate at which
individuals start treatment (𝜌).

(2) Matrix 𝐴 has a nonnegative right eigenvector 𝑤 and a
left eigenvector V corresponding to the zero eigenvalue.
Let 𝑓𝑘 be the 𝑘th component of 𝑓 and
𝑛

𝑎 = ∑ V𝑘 𝑤𝑖 𝑤𝑗
𝑘,𝑖,𝑗=1
𝑛

𝑛

20

𝜕2 𝑓𝑘
(0, 0) ,
𝜕𝑥𝑖 𝜕𝑥𝑗

𝜕2 𝑓𝑘
𝑏 = ∑ V𝑘 𝑤𝑖
(0, 0) .
𝜕𝑥𝑖 𝜕Φ
𝑘,𝑖=1

(A.3)

The local dynamics of (A.1) around 0 are totally determined by
a and b.
(1) Consider 𝑎 > 0, 𝑏 > 0. When Φ < 0 with |Φ| ≪ 1, 0 is
locally asymptotically stable, and there exists a positive
unstable equilibrium; when 0 < Φ ≪ 1, 0 is unstable
and there exists a negative and locally asymptotically
stable equilibrium.
(2) Consider 𝑎 < 0, 𝑏 < 0. When Φ < 0 with |Φ| ≪ 1, 0 is
unstable; when 0 < Φ ≪ 1, 0 is locally asymptotically
stable, and there exists a positive unstable equilibrium.
(3) Consider 𝑎 > 0, 𝑏 < 0. When Φ < 0 with |Φ| ≪ 1, 0 is
unstable, and there exists a locally asymptotically stable
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negative equilibrium; when 0 < Φ ≪ 1, 0 is stable, and
a positive unstable equilibrium appears.
(4) Consider 𝑎 < 0, 𝑏 > 0. When Φ < 0 changes
from negative to positive, 0 changes its stability from
stable to unstable. Correspondingly a negative unstable
equilibrium becomes positive and locally asymptotically
stable.

[2]

[3]

[4]

Notations
Λ 𝐻:
𝛾:
𝜙:
𝑝:

New recruitment to the human population
Recovery rate from malaria infected class
Recovery rate from malaria exposed class
Progress rate from exposed to malaria
infected
𝑤:
Relative reduction to HIV infection for 𝐼𝑀
𝜇, 𝜇𝑉:
Natural mortality rate for human,
mosquito population, respectively
Malaria induced mortality rate for
𝛿𝑀:
individuals in state 𝐼𝑀
𝛿𝐻:
HIV/AIDS induced mortality rate for
individuals in state 𝐼𝐻
𝛿𝐴 :
HIV/AIDS induced mortality rate for
individuals in state 𝐴 𝐻
𝛽𝐻:
HIV transmission probability
The biting rate of mosquitoes
𝑏𝑀:
The transmission probability per bite from
𝛽𝑀:
vector to human
The transmission probability per bite from
𝛽𝑉 :
human to vector
𝑞:
Recovery rate from malaria for coinfected
individuals
𝜎:
A factor which accounts for differential
recovery rate from malaria
Progression rates to AIDS stage
𝛼1,2,3,4 :
Rates at which individuals start treatment
𝜌1,2 :
Factors which account for differential
𝜖1,2 :
recovery rates
Factors which account for differential
𝜂1,2,3,4 :
malaria infection rates
𝜃1,2,3,4,5,6,7 : Factors indicating the differential
contribution for the HIV infection rates
Factors indicating the differential
𝑞1,2,3,4 :
contribution for the malaria infection rates
𝜑, 𝜏:
Factors which account for differential
AIDS induced death
The rate at which mosquitoes progress to
𝜃𝑉 :
infectious state.
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